These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2835437)

  • 1. Passive transfer of myasthenia gravis by immunoglobulins: lack of correlation between AChR with antibody bound, acetylcholine receptor loss and transmission defect.
    Mossman S; Vincent A; Newsom-Davis J
    J Neurol Sci; 1988 Mar; 84(1):15-28. PubMed ID: 2835437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity.
    Mossman S; Vincent A; Newsom-Davis J
    Lancet; 1986 Jan; 1(8473):116-9. PubMed ID: 2417076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunopathologic events at the endplate in myasthenia gravis.
    Ashizawa T; Appel SH
    Springer Semin Immunopathol; 1985; 8(3):177-96. PubMed ID: 2413561
    [No Abstract]   [Full Text] [Related]  

  • 4. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.
    Lindstrom JM; Engel AG; Seybold ME; Lennon VA; Lambert EH
    J Exp Med; 1976 Sep; 144(3):739-53. PubMed ID: 182897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myasthenia gravis: passive transfer to mice of antibody to human and mouse acetylcholine receptor.
    Oda K; Korenaga S; Ito Y
    Neurology; 1981 Mar; 31(3):282-7. PubMed ID: 6259556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN; Reddel SW; Gervásio OL; Phillips WD
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A myasthenia gravis plasma immunoglobulin reduces miniature endplate potentials at human endplates in vitro.
    Burges J; Wray DW; Pizzighella S; Hall Z; Vincent A
    Muscle Nerve; 1990 May; 13(5):407-13. PubMed ID: 2345558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunopathology of acquired myasthenia gravis.
    Engel AG; Sahashi K; Fumagalli G
    Ann N Y Acad Sci; 1981; 377():158-74. PubMed ID: 6951470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects.
    Viegas S; Jacobson L; Waters P; Cossins J; Jacob S; Leite MI; Webster R; Vincent A
    Exp Neurol; 2012 Apr; 234(2):506-12. PubMed ID: 22326541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A postnatal change in the immunological properties of the acetylcholine receptor at rat muscle endplates.
    Hall ZW; Gorin PD; Silberstein L; Bennett C
    J Neurosci; 1985 Mar; 5(3):730-4. PubMed ID: 3973693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic difference of acetylcholine receptor between single and multiple form endplates of human extraocular muscle.
    Oda K; Shibasaki H
    Brain Res; 1988 May; 449(1-2):337-40. PubMed ID: 2456129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo imaging shows loss of synaptic sites from neuromuscular junctions in a model of myasthenia gravis.
    Rich MM; Colman H; Lichtman JW
    Neurology; 1994 Nov; 44(11):2138-45. PubMed ID: 7969973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passive transfer of seronegative myasthenia gravis to mice.
    Burges J; Vincent A; Molenaar PC; Newsom-Davis J; Peers C; Wray D
    Muscle Nerve; 1994 Dec; 17(12):1393-400. PubMed ID: 7969240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myasthenia gravis: further electrophysiological and ultrastructural analysis of transmission failure in the mouse passive transfer model.
    Toyka KV; Birnberger KL; Anzil AP; Schlegel C; Besinger U; Struppler A
    J Neurol Neurosurg Psychiatry; 1978 Aug; 41(8):746-53. PubMed ID: 210263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Passively transferred myasthenia gravis: protection of mouse endplates by Fab fragments from human myasthenic IgG.
    Toyka KV; Löwenadler B; Heininger K; Besinger UA; Birnberger KL; Fateh-Moghadam A; Heilbronn E
    J Neurol Neurosurg Psychiatry; 1980 Sep; 43(9):836-42. PubMed ID: 6252294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylcholine receptor turnover in mice with passively transferred myasthenia gravis. I. Receptor degradation.
    Wilson S; Vincent A; Newsom-Davis J
    J Neurol Neurosurg Psychiatry; 1983 May; 46(5):377-82. PubMed ID: 6101171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental myasthenia: lack of correlation between the autoantibody titer and the reduction of acetylcholine-controlled ionic channels measured at functioning endplates.
    Hohlfeld R; Sterz R; Kalies I; Wekerle H; Peper K
    Muscle Nerve; 1983 Feb; 6(2):160-3. PubMed ID: 6304508
    [No Abstract]   [Full Text] [Related]  

  • 18. Refractoriness to a second episode of experimental myasthenia gravis. Correlation with AChR concentration and morphologic appearance of the postsynaptic membrane.
    Corey AL; Richman DP; Agius MA; Wollmann RL
    J Immunol; 1987 May; 138(10):3269-75. PubMed ID: 3494763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of rapsyn in rat muscle increases acetylcholine receptor levels in chronic experimental autoimmune myasthenia gravis.
    Martínez-Martínez P; Losen M; Duimel H; Frederik P; Spaans F; Molenaar P; Vincent A; De Baets MH
    Am J Pathol; 2007 Feb; 170(2):644-57. PubMed ID: 17255332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased uptake of acetylcholine-receptor antibody at motor endplate in myasthenic exacerbation.
    de Crousaz G; Fulpius BW
    Lancet; 1978 Jan; 1(8054):47. PubMed ID: 74528
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.